Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
AB Corporate Bond ETF stock logo
EYEG
AB Corporate Bond ETF
$35.06
-0.3%
$1.90
$1.44
$8.18
$24.54M0.13935,975 shs1 shs
Kazia Therapeutics Limited stock logo
KZIA
Kazia Therapeutics
$0.29
$0.30
$0.19
$1.39
$4.67M2.07670,747 shs149,181 shs
Sernova Corp. stock logo
SEOVF
Sernova
$0.28
$0.37
$0.26
$0.83
$84.92M1.219,324 shs25,600 shs
Zosano Pharma Co. stock logo
ZSAN
Zosano Pharma
$0.00
$3.90
$0.46
$37.45
$1K3.3425,375 shs5,685 shs
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
AB Corporate Bond ETF stock logo
EYEG
AB Corporate Bond ETF
+0.20%+0.84%-0.53%-0.51%+1,703.24%
Kazia Therapeutics Limited stock logo
KZIA
Kazia Therapeutics
-0.48%+1.88%-37.43%+6.12%-78.36%
Sernova Corp. stock logo
SEOVF
Sernova
-0.02%-5.92%-19.76%-36.89%-59.39%
Zosano Pharma Co. stock logo
ZSAN
Zosano Pharma
0.00%0.00%0.00%0.00%0.00%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
AB Corporate Bond ETF stock logo
EYEG
AB Corporate Bond ETF
N/AN/AN/AN/AN/AN/AN/AN/A
Kazia Therapeutics Limited stock logo
KZIA
Kazia Therapeutics
0.2091 of 5 stars
0.03.00.00.01.10.01.3
Sernova Corp. stock logo
SEOVF
Sernova
0.7849 of 5 stars
3.03.00.00.00.00.00.0
Zosano Pharma Co. stock logo
ZSAN
Zosano Pharma
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
AB Corporate Bond ETF stock logo
EYEG
AB Corporate Bond ETF
N/AN/AN/AN/A
Kazia Therapeutics Limited stock logo
KZIA
Kazia Therapeutics
N/AN/AN/AN/A
Sernova Corp. stock logo
SEOVF
Sernova
2.00
Hold$1.50435.05% Upside
Zosano Pharma Co. stock logo
ZSAN
Zosano Pharma
N/AN/AN/AN/A

Current Analyst Ratings

Latest ZSAN, SEOVF, EYEG, and KZIA Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/4/2024
Sernova Corp. stock logo
SEOVF
Sernova
Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageMarket Perform$1.50
(Data available from 5/10/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
AB Corporate Bond ETF stock logo
EYEG
AB Corporate Bond ETF
$10K2,454.24N/AN/A$1.26 per share27.83
Kazia Therapeutics Limited stock logo
KZIA
Kazia Therapeutics
$20K233.68N/AN/A$0.50 per share0.57
Sernova Corp. stock logo
SEOVF
Sernova
N/AN/AN/AN/A$0.03 per shareN/A
Zosano Pharma Co. stock logo
ZSAN
Zosano Pharma
$790K0.00N/AN/A$9.74 per share0.00

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
AB Corporate Bond ETF stock logo
EYEG
AB Corporate Bond ETF
-$8.09M-$1.68N/AN/AN/AN/A-104.96%-60.03%N/A
Kazia Therapeutics Limited stock logo
KZIA
Kazia Therapeutics
-$13.78MN/A0.00N/AN/AN/AN/AN/AN/A
Sernova Corp. stock logo
SEOVF
Sernova
-$28.91M-$0.09N/AN/AN/A-226.64%-145.26%6/12/2024 (Estimated)
Zosano Pharma Co. stock logo
ZSAN
Zosano Pharma
-$29.92M-$14.50N/AN/A-8,375.11%-177.06%-119.14%N/A

Latest ZSAN, SEOVF, EYEG, and KZIA Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
3/18/2024Q1 2024
Sernova Corp. stock logo
SEOVF
Sernova
N/A-$0.02-$0.02-$0.02N/AN/A

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
AB Corporate Bond ETF stock logo
EYEG
AB Corporate Bond ETF
N/AN/AN/AN/AN/A
Kazia Therapeutics Limited stock logo
KZIA
Kazia Therapeutics
N/AN/AN/AN/AN/A
Sernova Corp. stock logo
SEOVF
Sernova
N/AN/AN/AN/AN/A
Zosano Pharma Co. stock logo
ZSAN
Zosano Pharma
N/AN/AN/AN/AN/A

Latest ZSAN, SEOVF, EYEG, and KZIA Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/30/2024
AB Corporate Bond ETF stock logo
EYEG
AB Corporate Bond ETF
Monthly$0.14845/1/20245/2/20245/7/2024
3/28/2024
AB Corporate Bond ETF stock logo
EYEG
AB Corporate Bond ETF
Monthly$0.15724/1/20244/2/20244/5/2024
2/29/2024
AB Corporate Bond ETF stock logo
EYEG
AB Corporate Bond ETF
Monthly$0.14863/1/20243/4/20243/7/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
AB Corporate Bond ETF stock logo
EYEG
AB Corporate Bond ETF
0.01
3.07
3.07
Kazia Therapeutics Limited stock logo
KZIA
Kazia Therapeutics
N/A
0.71
N/A
Sernova Corp. stock logo
SEOVF
Sernova
0.14
1.20
1.20
Zosano Pharma Co. stock logo
ZSAN
Zosano Pharma
N/A
1.61
1.61

Ownership

Institutional Ownership

CompanyInstitutional Ownership
AB Corporate Bond ETF stock logo
EYEG
AB Corporate Bond ETF
64.16%
Kazia Therapeutics Limited stock logo
KZIA
Kazia Therapeutics
30.89%
Sernova Corp. stock logo
SEOVF
Sernova
N/A
Zosano Pharma Co. stock logo
ZSAN
Zosano Pharma
N/A

Insider Ownership

CompanyInsider Ownership
AB Corporate Bond ETF stock logo
EYEG
AB Corporate Bond ETF
58.20%
Kazia Therapeutics Limited stock logo
KZIA
Kazia Therapeutics
1.00%
Sernova Corp. stock logo
SEOVF
Sernova
N/A
Zosano Pharma Co. stock logo
ZSAN
Zosano Pharma
2.40%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
AB Corporate Bond ETF stock logo
EYEG
AB Corporate Bond ETF
14700,0005.28 millionNot Optionable
Kazia Therapeutics Limited stock logo
KZIA
Kazia Therapeutics
2,02116.34 million16.18 millionOptionable
Sernova Corp. stock logo
SEOVF
Sernova
N/A303.41 millionN/ANot Optionable
Zosano Pharma Co. stock logo
ZSAN
Zosano Pharma
404.90 million4.78 millionNot Optionable

ZSAN, SEOVF, EYEG, and KZIA Headlines

SourceHeadline
HOOK HOOKIPA Pharma Inc.HOOK HOOKIPA Pharma Inc.
seekingalpha.com - April 12 at 10:11 PM
Nachrichten - Weitere NachrichtenNachrichten - Weitere Nachrichten
wallstreet-online.de - January 9 at 2:39 PM
LISTEN: Supreme Court hears arguments on legality of Purdue Pharma bankruptcy planLISTEN: Supreme Court hears arguments on legality of Purdue Pharma bankruptcy plan
pbs.org - December 6 at 7:44 AM
Der Börsen-Tag: Diese US-Aktie stürzte nachbörslich abDer Börsen-Tag: Diese US-Aktie stürzte nachbörslich ab
n-tv.de - August 22 at 3:36 PM
East Bay Business NewsEast Bay Business News
bizjournals.com - May 18 at 9:49 PM
Mankind Pharma IPO opens on April 25, listing scheduled for May 9Mankind Pharma IPO opens on April 25, listing scheduled for May 9
moneycontrol.com - April 27 at 4:20 PM
Astellas PharmaAstellas Pharma
forbes.com - April 6 at 12:00 PM
Giiant Pharma Receives Financial Support From the US Crohn’s and Colitis FoundationGiiant Pharma Receives Financial Support From the US Crohn’s and Colitis Foundation
finance.yahoo.com - February 5 at 12:11 PM
FTC asks court to hold pharma bro Martin Shkreli in contempt for failing to abide by ordersFTC asks court to hold 'pharma bro' Martin Shkreli in contempt for failing to abide by orders
washingtonexaminer.com - January 23 at 3:25 PM
Zosano Pharma Corporation (ZSANQ)Zosano Pharma Corporation (ZSANQ)
ca.finance.yahoo.com - November 5 at 6:33 PM
Now bank­rupt, Zosano sells off its drug de­liv­ery tech that once en­ticed No­vo Nordisk, Eli Lil­lyNow bank­rupt, Zosano sells off its drug de­liv­ery tech that once en­ticed No­vo Nordisk, Eli Lil­ly
endpts.com - October 13 at 11:22 AM
Bankrupt Zosano Sells Its Drug Delivery Tech That Once Partnered With Pharma GiantsBankrupt Zosano Sells Its Drug Delivery Tech That Once Partnered With Pharma Giants
msn.com - October 12 at 2:32 PM
Bankrupt Zosano Pharma Says Unsecured Creditors Will Recoup 28% of ClaimsBankrupt Zosano Pharma Says Unsecured Creditors Will Recoup 28% of Claims
marketwatch.com - August 28 at 7:45 PM
East Bay migraine patch developer Zosano closes sale in bankruptcy court for $1 millionEast Bay migraine patch developer Zosano closes sale in bankruptcy court for $1 million
bizjournals.com - August 27 at 4:10 PM
Zosano Pharma Corp (ZSANQ)Zosano Pharma Corp (ZSANQ)
investing.com - August 25 at 12:28 AM
East Bay company promised drug-coated microneedle patches. Now it could be sold in bankruptcy court for just $1MEast Bay company promised drug-coated microneedle patches. Now it could be sold in bankruptcy court for just $1M
bizjournals.com - July 26 at 8:27 PM
A Fremont company promised drug-coated microneedle patches. Now it could be sold in bankruptcy court for just $1M.A Fremont company promised drug-coated microneedle patches. Now it could be sold in bankruptcy court for just $1M.
bizjournals.com - July 26 at 8:27 PM
Zosano Pharma Corporation [ZSAN] stock Initiated by Maxim Group analyst, price target now $8Zosano Pharma Corporation [ZSAN] stock Initiated by Maxim Group analyst, price target now $8
dbtnews.com - June 3 at 11:27 AM
Zosano Pharma Shares Slide to New Depths After Chapter 11 Filing >ZSANZosano Pharma Shares Slide to New Depths After Chapter 11 Filing >ZSAN
marketwatch.com - June 2 at 3:26 PM
Why Zosano Pharma Shares Are Getting Hammered TodayWhy Zosano Pharma Shares Are Getting Hammered Today
msn.com - June 2 at 3:26 PM
Zosano Pharma files for Chapter 11 bankruptcy protection; shares plummet 46%Zosano Pharma files for Chapter 11 bankruptcy protection; shares plummet 46%
seekingalpha.com - June 2 at 10:26 AM
Cash-Strapped Zosano Pharma Files for Chapter 11 Bankruptcy >ZSANCash-Strapped Zosano Pharma Files for Chapter 11 Bankruptcy >ZSAN
marketwatch.com - June 2 at 10:26 AM
East Bay migraine patch developer files for bankruptcyEast Bay migraine patch developer files for bankruptcy
bizjournals.com - June 2 at 10:26 AM
Zosano Pharma Files Voluntary Petition for Relief Under Chapter 11Zosano Pharma Files Voluntary Petition for Relief Under Chapter 11
finance.yahoo.com - June 2 at 10:26 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

AB Corporate Bond ETF logo

AB Corporate Bond ETF

NASDAQ:EYEG
EyeGate Pharmaceuticals, Inc. is a clinical stage specialty pharmaceutical company, which engages in the development and commercialization of products for treating diseases and disorders of the eye. Its pipeline includes MoxiGel and Ocular Bandage Gel. The company was founded in 1998 and is headquartered in Waltham, MA.
Kazia Therapeutics logo

Kazia Therapeutics

NASDAQ:KZIA
Kazia Therapeutics Limited operates as a biotechnology company, develops anti-cancer drugs. Its lead development candidate is Paxalisib, a small molecule, brain-penetrant inhibitor of the PI3K/AKT/mTOR pathway, which is developed as a potential therapy for glioblastoma, diffuse intrinsic pontine glioma/advanced solid tumors, atypical teratoid rhabdoid tumor, brain metastases, triple negative breast cancer, and primary central nervous system lymphoma. It is also developing EVT801, a small molecule targeted therapeutic vascular endothelial growth factor receptor 3 inhibitor. The company was formerly known as Novogen Limited and changed its name to Kazia Therapeutics Limited in November 2017. The company was incorporated in 1994 and is based in Sydney, Australia.
Sernova logo

Sernova

OTCMKTS:SEOVF
Sernova Corp. operates as a clinical-stage regenerative medicine therapeutics company in Canada. The company focuses on the development and commercialization of regenerative medicine therapeutics, including its proprietary Cell Pouch and associated technologies consisting of therapeutic cells and local cellular immune protection. Its Cell Pouch is a novel implantable and scalable medical device which forms a natural environment in the body for the housing and long-term survival and function of therapeutic cells, which release necessary proteins or factors missing from the body to treat chronic diseases as an alternative to daily administration of drugs. Sernova Corp. has a research agreement with the University of Miami to advance the development of Conformal Coating Technology in combination with therapeutic cells within Cell Pouch. Sernova Corp. was incorporated in 1998 and is headquartered in London, Canada.
Zosano Pharma logo

Zosano Pharma

NASDAQ:ZSAN
Zosano Pharma Corporation, a clinical stage biopharmaceutical company, focuses on providing therapeutics and other bioactive molecules to patients suffering from migraine using its transdermal microneedle system. Its lead product candidate is Qtrypta (M207), a proprietary formulation of zolmitriptan used for the acute treatment of migraine. The company was founded in 2006 and is headquartered in Fremont, California.